Corvus Pharmaceuticals
CRVS
#7822
Rank
C$0.34 B
Marketcap
$5.08
Share price
3.98%
Change (1 day)
145.55%
Change (1 year)

EPS for Corvus Pharmaceuticals (CRVS)

EPS in 2023 (TTM): -$1.14

According to Corvus Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$1.17. In 2022 the company made an earnings per share (EPS) of -$1.24 an increase over its 2021 EPS that were of -$1.47.

EPS history for Corvus Pharmaceuticals from 2015 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.14-7.9%
2022-$1.24-16.04%
2021-$1.47404.76%
2020-$0.29-86.79%
2019-$2.21-9.14%
2018-$2.43-35.66%
2017-$3.78-60.47%
2016-$9.55348.05%
2015-$2.13

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.03 159.52%๐Ÿ‡บ๐Ÿ‡ธ USA